Cardiovascular Adverse Events (CVAE) Associated With Second Generation Bruton Tyrosine Kinase (BTK) Inhibitor (BTKi) Therapy in Patients With Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Meta-Analysis

被引：0

作者：

Proskuriakova, Ekaterina ^{[1
]}

Shrestha, Dhan ^{[1
]}

Jasaraj, Ranjit ^{[1
]}

Mercado, Gustavo Espinoza ^{[1
]}

Wortstman, Josh ^{[1
]}

Kovalenko, Iulia ^{[2
]}

Khosla, Pam ^{[1
]}

机构：

[1] Mt Sinai Hosp, Chicago, IL USA

[2] UPMC, Harrisburg, PA USA

来源：

关键词：

CLL; Bruton tyrosine kinase inhibitor; acalabrutinib; zanubrutinib;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CLL-428

引用

页码：S327 / S328

页数：2